1
|
Dimaras H, Corson TW, Cobrinik D, White A,
Zhao J, Munier FL, Abramson DH, Shields CL, Chantada GL, Njuguna F,
et al: Retinoblastoma. Nat Rev Dis Primers. 1:150212015. View Article : Google Scholar : PubMed/NCBI
|
2
|
MacCarthy A, Draper GJ, Steliarova-Foucher
E and Kingston JE: Retinoblastoma incidence and survival in
European children (1978–1997). Report from the Automated Childhood
Cancer Information System project. Eur J Cancer. 42:2092–2102.
2006. View Article : Google Scholar : PubMed/NCBI
|
3
|
Houston SK, Murray TG, Wolfe SQ and
Fernandes CE: Current update on retinoblastoma. Int Ophthalmol
Clin. 51:77–91. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Shields CL and Shields JA: Retinoblastoma
management: Advances in enucleation, intravenous chemoreduction,
and intra-arterial chemotherapy. Curr Opin Ophthalmol. 21:203–212.
2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Abramson DH, Shields CL, Munier FL and
Chantada GL: Treatment of retinoblastoma in 2015: Agreement and
disagreement. JAMA Ophthalmol. 133:1341–1347. 2015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Mendoza PR and Grossniklaus HE:
Therapeutic options for retinoblastoma. Cancer Control. 23:99–109.
2016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Kaliki S, Shields CL, Rojanaporn D,
Al-Dahmash S, McLaughlin JP, Shields JA and Eagle RC Jr: High-risk
retinoblastoma based on international classification of
retinoblastoma: Analysis of 519 enucleated eyes. Ophthalmology.
120:997–1003. 2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Benavente CA and Dyer MA: Genetics and
epigenetics of human retinoblastoma. Annu Rev Pathol. 10:547–562.
2015. View Article : Google Scholar : PubMed/NCBI
|
9
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
10
|
Bracken CP, Scott HS and Goodall GJ: A
network-biology perspective of microRNA function and dysfunction in
cancer. Nat Rev Genet. 17:719–732. 2016. View Article : Google Scholar : PubMed/NCBI
|
11
|
Cai Y, Yu X, Hu S and Yu J: A brief review
on the mechanisms of miRNA regulation. Genomics Proteomics
Bioinformatics. 7:147–154. 2009. View Article : Google Scholar : PubMed/NCBI
|
12
|
Vasudevan S, Tong Y and Steitz JA:
Switching from repression to activation: MicroRNAs can up-regulate
translation. Science. 318:1931–1934. 2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Golabchi K, Soleimani-Jelodar R, Aghadoost
N, Momeni F, Moridikia A, Nahand JS, Masoudifar A, Razmjoo H and
Mirzaei H: MicroRNAs in retinoblastoma: Potential diagnostic and
therapeutic biomarkers. J Cell Physiol. 233:3016–3023. 2018.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Wu L, Chen Z and Xing Y: MiR-506-3p
inhibits cell proliferation, induces cell cycle arrest and
apoptosis in retinoblastoma by directly targeting NEK6. Cell Biol
Int. Aug 6–2018.(Epub ahead of print). doi: 10.1002/cbin.11041.
View Article : Google Scholar
|
15
|
Wu S, Ai N, Liu Q and Zhang J: MicroRNA448
inhibits the progression of retinoblastoma by directly targeting
ROCK1 and regulating PI3K/AKT signalling pathway. Oncol Rep.
39:2402–2412. 2018.PubMed/NCBI
|
16
|
Liu H, Cao B, Zhao Y, Liang H and Liu X:
Upregulated miR-221/222 promotes cell proliferation and invasion
and is associated with invasive features in retinoblastoma. Cancer
Biomark. 22:621–629. 2018. View Article : Google Scholar : PubMed/NCBI
|
17
|
Li J, Xu J, Yan X, Jin K, Li W and Zhang
R: MicroRNA-485 plays tumour-suppressive roles in colorectal cancer
by directly targeting GAB2. Oncol Rep. 40:554–564. 2018.PubMed/NCBI
|
18
|
Hu XX, Xu XN, He BS, Sun HL, Xu T, Liu XX,
Chen XX, Zeng KX, Wang SK and Pan YQ: microRNA-485-5p functions as
a tumor suppressor in colorectal cancer cells by targeting CD147. J
Cancer. 9:2603–2611. 2018. View Article : Google Scholar : PubMed/NCBI
|
19
|
Jing LL and Mo XM: Reduced miR-485-5p
expression predicts poor prognosis in patients with gastric cancer.
Eur Rev Med Pharmacol Sci. 20:1516–1520. 2016.PubMed/NCBI
|
20
|
Mao K, Lei D, Zhang H and You C:
MicroRNA-485 inhibits malignant biological behaviour of
glioblastoma cells by directly targeting PAK4. Int J Oncol.
51:1521–1532. 2017. View Article : Google Scholar : PubMed/NCBI
|
21
|
Wang ZQ, Zhang MY, Deng ML, Weng NQ, Wang
HY and Wu SX: Low serum level of miR-485-3p predicts poor survival
in patients with glioblastoma. PLoS One. 12:e01849692017.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
23
|
Misiewicz-Krzeminska I, Krzeminski P,
Corchete LA, Quwaider D, Rojas EA, Herrero AB and Gutiérrez NC:
Factors regulating microRNA expression and function in multiple
myeloma. Noncoding RNA. 5:2019.PubMed/NCBI
|
24
|
Henry JC, Azevedo-Pouly AC and Schmittgen
TD: MicroRNA replacement therapy for cancer. Pharm Res.
28:3030–3042. 2011. View Article : Google Scholar : PubMed/NCBI
|
25
|
Ors-Kumoglu G, Gulce-Iz S and Biray-Avci
C: Therapeutic microRNAs in human cancer. Cytotechnology.
71:411–425. 2019. View Article : Google Scholar : PubMed/NCBI
|
26
|
He S, Lu Y, Liu X, Huang X, Keller ET,
Qian CN and Zhang J: Wnt3a: Functions and implications in cancer.
Chin J Cancer. 34:554–562. 2015. View Article : Google Scholar : PubMed/NCBI
|
27
|
Oguma J, Ozawa S, Kazuno A, Nitta M,
Ninomiya Y and Kajiwara H: Wnt3a expression is associated with poor
prognosis of esophageal squamous cell carcinoma. Oncol Lett.
15:3100–3108. 2018.PubMed/NCBI
|
28
|
Qi L, Sun B, Liu Z, Cheng R, Li Y and Zhao
X: Wnt3a expression is associated with epithelial-mesenchymal
transition and promotes colon cancer progression. J Exp Clin Cancer
Res. 33:1072014. View Article : Google Scholar : PubMed/NCBI
|
29
|
Zhang J, He J and Zhang L: The
down-regulation of microRNA-137 contributes to the up-regulation of
retinoblastoma cell proliferation and invasion by regulating
COX-2/PGE2 signaling. Biomed Pharmacother. 106:35–42. 2018.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Miao X, Wang Z, Chen B, Chen Y, Wang X,
Jiang L, Jiang S, Hao K and Zhang W: miR-140-5p suppresses
retinoblastoma cell proliferation, migration, and invasion by
targeting CEMIP and CADM3. Cell Mol Biol. 64:42–47. 2018.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Yang L, Wei N, Wang L, Wang X and Liu QH:
miR-498 promotes cell proliferation and inhibits cell apoptosis in
retinoblastoma by directly targeting CCPG1. Childs Nerv Syst.
34:417–422. 2018. View Article : Google Scholar : PubMed/NCBI
|
32
|
Yong-Ming H, Ai-Jun J, Xiao-Yue X,
Jian-Wei L, Chen Y and Ye C: miR-449a: A potential therapeutic
agent for cancer. Anticancer Drugs. 28:1067–1078. 2017. View Article : Google Scholar : PubMed/NCBI
|
33
|
Singh U, Malik MA, Goswami S, Shukla S and
Kaur J: Epigenetic regulation of human retinoblastoma. Tumour Biol.
37:14427–14441. 2016. View Article : Google Scholar : PubMed/NCBI
|
34
|
Mirakholi M, Mahmoudi T and Heidari M:
MicroRNAs horizon in retinoblastoma. Acta Med Iran. 51:823–829.
2013.PubMed/NCBI
|
35
|
Guo GX, Li QY, Ma WL, Shi ZH and Ren XQ:
MicroRNA-485-5p suppresses cell proliferation and invasion in
hepatocellular carcinoma by targeting stanniocalcin 2. Int J Clin
Exp Pathol. 8:12292–12299. 2015.PubMed/NCBI
|
36
|
Sun X, Liu Y, Li M, Wang M and Wang Y:
Involvement of miR-485-5p in hepatocellular carcinoma progression
targeting EMMPRIN. Biomed Pharmacother. 72:58–65. 2015. View Article : Google Scholar : PubMed/NCBI
|
37
|
Mou X and Liu S: MiR-485 inhibits
metastasis and EMT of lung adenocarcinoma by targeting Flot2.
Biochem Biophys Res Commun. 477:521–526. 2016. View Article : Google Scholar : PubMed/NCBI
|
38
|
Lou C, Xiao M, Cheng S, Lu X, Jia S, Ren Y
and Li Z: MiR-485-3p and miR-485-5p suppress breast cancer cell
metastasis by inhibiting PGC-1α expression. Cell Death Dis.
7:e21592016. View Article : Google Scholar : PubMed/NCBI
|
39
|
Anaya-Ruiz M, Bandala C and Perez-Santos
JL: miR-485 acts as a tumor suppressor by inhibiting cell growth
and migration in breast carcinoma T47D cells. Asian Pac J Cancer
Prev. 14:3757–3760. 2013. View Article : Google Scholar : PubMed/NCBI
|
40
|
Chen Z, Li Q, Wang S and Zhang J: miR4855p
inhibits bladder cancer metastasis by targeting HMGA2. Int J Mol
Med. 36:1136–1142. 2015. View Article : Google Scholar : PubMed/NCBI
|
41
|
Kang M, Ren MP, Zhao L, Li CP and Deng MM:
miR-485-5p acts as a negative regulator in gastric cancer
progression by targeting flotillin-1. Am J Transl Res. 7:2212–2222.
2015.PubMed/NCBI
|
42
|
Duan J, Zhang H, Li S, Wang X, Yang H,
Jiao S and Ba Y: The role of miR-485-5p/NUDT1 axis in gastric
cancer. Cancer Cell Int. 17:922017. View Article : Google Scholar : PubMed/NCBI
|
43
|
Yu J, Wu SW and Wu WP: A tumor-suppressive
microRNA, miRNA-485-5p, inhibits glioma cell proliferation and
invasion by down-regulating TPD52L2. Am J Transl Res. 9:3336–3344.
2017.PubMed/NCBI
|
44
|
Wu J, Li J, Ren J and Zhang D:
MicroRNA-485-5p represses melanoma cell invasion and proliferation
by suppressing Frizzled7. Biomed Pharmacother. 90:303–310. 2017.
View Article : Google Scholar : PubMed/NCBI
|
45
|
Lin XJ, He CL, Sun T, Duan XJ, Sun Y and
Xiong SJ: hsa-miR-485-5p reverses epithelial to mesenchymal
transition and promotes cisplatin-induced cell death by targeting
PAK1 in oral tongue squamous cell carcinoma. Int J Mol Med.
40:83–89. 2017. View Article : Google Scholar : PubMed/NCBI
|
46
|
Sun R, Liu Z, Tong D, Yang Y, Guo B, Wang
X, Zhao L and Huang C: miR-491-5p, mediated by Foxi1, functions as
a tumor suppressor by targeting Wnt3a/β-catenin signaling in the
development of gastric cancer. Cell Death Dis. 8:e27142017.
View Article : Google Scholar : PubMed/NCBI
|
47
|
Lee MA, Park JH, Rhyu SY, Oh ST, Kang WK
and Kim HN: Wnt3a expression is associated with MMP-9 expression in
primary tumor and metastatic site in recurrent or stage IV
colorectal cancer. BMC Cancer. 14:1252014. View Article : Google Scholar : PubMed/NCBI
|
48
|
Xu J, Lv W, Hu Y, Wang L, Wang Y, Cao J
and Hu J: Wnt3a expression is associated with
epithelial-mesenchymal transition and impacts prognosis of lung
adenocarcinoma patients. J Cancer. 8:2523–2531. 2017. View Article : Google Scholar : PubMed/NCBI
|
49
|
Lu F, Ye Y, Zhang H, He X, Sun X, Yao C,
Mao H, He X, Qian C, Wang B, et al: miR-497/Wnt3a/c-jun feedback
loop regulates growth and epithelial-to-mesenchymal transition
phenotype in glioma cells. Int J Biol Macromol. 120:985–991. 2018.
View Article : Google Scholar : PubMed/NCBI
|